Christopher J. Horvath

Person

Taunton, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Humanized anti-CCR2 antibodies and methods of use therefor
- Patent number 8,926,971
- Issue date Jan 6, 2015
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CCR2 antibodies and methods of use therefor
- Patent number 8,227,211
- Issue date Jul 24, 2012
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CCR2 antibodies and methods of use therefor
- Patent number 7,566,450
- Issue date Jul 28, 2009
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CCR2 antibodies and methods of use therefor
- Patent number 7,473,421
- Issue date Jan 6, 2009
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CCR2 antibodies and methods of use therefor
- Patent number 7,442,775
- Issue date Oct 28, 2008
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant anti-CCR2 antibodies and methods of use therefor
- Patent number 6,727,349
- Issue date Apr 27, 2004
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CCR2 antibodies and methods of use therefor
- Patent number 6,696,550
- Issue date Feb 24, 2004
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of inhibiting stenosis and restenosis
- Patent number 6,663,863
- Issue date Dec 16, 2003
- Millennium Pharmaceuticals, Inc.
- Christopher J. Horvath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CCR2 antibodies and methods of use therefor
- Patent number 6,352,832
- Issue date Mar 5, 2002
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR
- Publication number 20150086546
- Publication date Mar 26, 2015
- Millennium Pharmaceuticals, Inc.
- Gregory J. Larosa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR
- Publication number 20130071381
- Publication date Mar 21, 2013
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR
- Publication number 20090191192
- Publication date Jul 30, 2009
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
- Publication number 20090169541
- Publication date Jul 2, 2009
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
- Publication number 20090142339
- Publication date Jun 4, 2009
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
- Publication number 20080268536
- Publication date Oct 30, 2008
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
- Publication number 20080241136
- Publication date Oct 2, 2008
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
- Publication number 20080241923
- Publication date Oct 2, 2008
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modified antibodies to prostate-specific membrane antigen and uses...
- Publication number 20060062793
- Publication date Mar 23, 2006
- Iain J. Webb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of inhibiting stenosis and restenosis
- Publication number 20050214299
- Publication date Sep 29, 2005
- Millennium Pharmaceuticals, Inc.
- Christopher J. Horvath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized anti-CCR2 antibodies and methods of use therefor
- Publication number 20040132980
- Publication date Jul 8, 2004
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized anti-CCR2 antibodies and methods of use therefor
- Publication number 20040126851
- Publication date Jul 1, 2004
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD18-binding antibodies and use thereof for inhibition and alleviat...
- Publication number 20040101527
- Publication date May 27, 2004
- Millennium Pharmaceuticals, Inc., a Delaware corporation
- Christopher J. Horvath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized anti-CCR2 antibodies and methods of use therefor
- Publication number 20020150576
- Publication date Oct 17, 2002
- Gregory J. LaRosa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method of inhibiting stenosis and restenosis
- Publication number 20020106369
- Publication date Aug 8, 2002
- Millennium Pharmaceuticals, Inc.
- Christopher J. Horvath
- C07 - ORGANIC CHEMISTRY

Christopher J. Horvath

Person

Patents Grantslast 30 patents

Humanized anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor

Recombinant anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor

Method of inhibiting stenosis and restenosis

Anti-CCR2 antibodies and methods of use therefor

Patents Applicationslast 30 patents

HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR

HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR

HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR

Humanized Anti-CCR2 Antibodies and Methods of Use Therefor

Humanized Anti-CCR2 Antibodies and Methods of Use Therefor

Humanized Anti-CCR2 Antibodies and Methods of Use Therefor

Humanized Anti-CCR2 Antibodies and Methods of Use Therefor

Humanized Anti-CCR2 Antibodies and Methods of Use Therefor

Modified antibodies to prostate-specific membrane antigen and uses...

Method of inhibiting stenosis and restenosis

Humanized anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor

CD18-binding antibodies and use thereof for inhibition and alleviat...

Humanized anti-CCR2 antibodies and methods of use therefor

Method of inhibiting stenosis and restenosis